サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1226701

ビタミンK2の世界市場：現状分析と予測（2022年～2028年）

Vitamin K2 Market: Current Analysis and Forecast (2022-2028)
出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 149 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ビタミンK2の世界市場：現状分析と予測（2022年～2028年）
出版日: 2023年01月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 149 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のビタミンK2の市場規模は、予測期間中に約25％の安定した成長が見込まれています。ビタミン欠乏症の患者層の拡大、ビタミンK2を含む製品の需要の高まり、関節炎の症例の増加などが市場の成長を牽引しています。

当レポートでは、世界のビタミンK2市場について調査分析し、市場概要、セグメント別・地域別の市場分析、市場成長への影響因子、市場動向、競合情勢、主要企業プロファイルなどを提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法と前提

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 ビタミンK2市場に対するCOVID-19の影響

第6章 ビタミンK2市場収益（2020年～2028年）

第7章 市場の洞察：由来別

  • 天然
  • 合成

第8章 市場の洞察：製品別

  • MK-4
  • MK-7
  • その他

第9章 市場の洞察：用途別

  • 医薬品
  • 栄養補助食品と食品
  • その他

第10章 市場の洞察：地域別

  • 北米
    • 米国
    • カナダ
    • その他北米
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋
  • 世界のその他の地域

第11章 ビタミンK2市場力学

  • 市場促進要因
  • 市場の課題
  • 影響分析

第12章 ビタミンK2市場機会

第13章 ビタミンK2市場動向

第14章 需要・供給分析

  • 需要分析
  • 供給分析

第15章 バリューチェーン分析

第16章 競合シナリオ

  • 競合情勢
    • ポーターのファイブフォース分析

第17章 会社概要

  • DSM
  • SEEBIO BIOTECH（SHANGHAI）CO., LTD.
  • Viridis BioPharma Pvt. Ltd.
  • Lesaffre
  • KYOWA HAKKO BIO CO,. LTD.
  • International Flavors & Fragrances Inc.
  • GeneFerm Biotechnology Co., Ltd.
  • DuPont
  • Kappa Bioscience
  • Vox Nutrition

第18章 免責事項

目次
Product Code: UMME211588

The vitamin K2 Market is expected to grow at a steady rate of around 25% during the forecast period. Vitamin K2 is naturally produced in human intestines by bacteria. The western diet is deficient in vitamin K2; hence pharmaceuticals and supplemental diets are required to provide vitamin K2. The market is expanding as a result of an expanding patient base with vitamin deficiencies, rising demand for products containing Vitamin K2, and rising cases of arthritis. For instance, according to the Centers for Disease Control and Prevention (CDC), around 1 in 4 US adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis.

Along with calcium and vitamin D, vitamin K2 may be an effective supplement for the treatment of osteoporosis that is toxic-free and comparable to bisphosphonate therapy. By reducing arterial calcification, it may also considerably reduce cardiovascular morbidity and mortality. In the cases of diabetes, cancer, and osteoarthritis, vitamin K2 appears promising. Although a dosage adjustment is necessary, the use of vitamin K during warfarin medication is safe and may help with INR (International Normalized Ratio) control.

Based on source, the market is segmented into natural and synthetic. Among them, synthetic category to witness higher CAGR during the forecast period. The high rate of production, an increase in vitamin deficiency disorders, increasing health awareness, and substantial economic expansion for nutritional supplements are the major factors for the growth of the vitamin K2 market.

On the basis of product, the market is categorized into MK-4, MK-7, and others. Among these, the MK-7 to hold a significant share in the market in 2020. This is mainly due to the growing usage of dietary supplements rising cases of coronary artery diseases because MK-7 based vitamin's reduces the risk of coronary artery diseases, and vitamin K2 as MK-7, improves bone density by making blood vessels softer and bones harder.

Based on application, the vitamin K2 market has been classified into pharmaceuticals, nutraceuticals & food, and others. The pharmaceuticals category is to witness a significant growth rate during the forecast period. This is mainly due to the changing food habits, changing lifestyle, health awareness, and standard of living. Also, the applications of vitamin K2 is useful in pharmaceutical industry focusing on dental, CVDs, and bone related deficiencies which will drive the market growth during the forecast period.

For a better understanding of the market adoption of the vitamin K2 industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the prevalence of effective medical facilities in nations like the United States and Canada, the rising use of herbal medicines, increasing healthcare expenditures, and the government's emphasis on health and wellness. Moreover, the inclination toward living a healthy life is leading to the growing consumption of supplements including vitamin K2 and the expansion of the food and beverage and cosmetic industries are the driving factors for the expansion of the regional market.

Some of the major players operating in the market include: DSM, SEEBIO BIOTECH (SHANGHAI) CO., LTD., Viridis BioPharma Pvt. Ltd., Lesaffre, KYOWA HAKKO BIO CO. LTD., International Flavors & Fragrances Inc., GeneFerm Biotechnology Co. Ltd., DuPont, Kappa Bioscience, Vox Nutrition

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Vitamin K2 Market
  • 2.2. Research Methodology of the Vitamin K2 Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE VITAMIN K2 MARKET

6 VITAMIN K2 MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY SOURCE

  • 7.1. Natural
  • 7.2. Synthetic

8 MARKET INSIGHTS BY PRODUCT

  • 8.1. MK-4
  • 8.2. MK-7
  • 8.3. Others

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Pharmaceuticals
  • 9.2. Nutraceuticals & Food
  • 9.3. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 VITAMIN K2 MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 VITAMIN K2 MARKET OPPORTUNITIES

13 VITAMIN K2 MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. DSM
  • 17.2. SEEBIO BIOTECH (SHANGHAI) CO., LTD.
  • 17.3. Viridis BioPharma Pvt. Ltd.
  • 17.4. Lesaffre
  • 17.5. KYOWA HAKKO BIO CO., LTD.
  • 17.6. International Flavors & Fragrances Inc.
  • 17.7. GeneFerm Biotechnology Co., Ltd.
  • 17.8. DuPont
  • 17.9. Kappa Bioscience
  • 17.10. Vox Nutrition

18 DISCLAIMER